Plus Therapeutics Inc. (PSTV)
undefined
undefined%
At close: undefined
1.24
-0.80%
After-hours Dec 13, 2024, 06:44 PM EST

Plus Therapeutics Inc. Forcast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for PSTV stock have an median target of 13.5, with a low estimate of 8 and a high estimate of 19. The median target predicts an increase of 980.00% from the current stock price of 1.25.

Analyst Consensus: Buy
Target Low Average Median High
Price $8 $13.5 $13.5 $19
Change 540.00% 980.00% 980.00% 1420.00%

AI Analyst Report

Ascendiant Capital reiterated a Buy rating on Plus... Unlock content with Pro Subscription

Updated Dec 09, 2024

Rating Aug 24Sep 24Nov 24Dec 24
Strong Buy 0000
Buy 1121
Hold 0000
Sell 0000
Strong Sell 0000
Total 1 1 2 1

Financial Forecast this Year

Revenue This Year
5.25M
from 4.91M
Increased by 6.9%
Revenue Next Year
3.74M
from 5.25M
Increased by -28.8%
EPS This Year
-2.23
from -4.24
Increased by 47.4%
EPS Next Year
-2.06
from -2.23
Increased by 7.6%